Latest News and Press Releases
Want to stay updated on the latest news?
-
RESEARCH TRIANGLE PARK, N.C. and DURHAM, N.C., June 06, 2019 (GLOBE NEWSWIRE) -- Tergus Pharma (“Tergus”), an end-to-end service provider for topical pharmaceutical research, drug development,...
-
DURHAM, N.C., April 25, 2018 (GLOBE NEWSWIRE) -- Tergus today announced key leadership changes to improve performance and accelerate growth. A key component of this stage in Tergus’ expansion is...
-
RESEARCH TRIANGLE PARK, N.C., March 22, 2018 (GLOBE NEWSWIRE) -- Tergus Pharma, LLC, the leading global provider of dermatology Contract Research Organization (CRO) Services, today announced that it...
-
RALEIGH-DURHAM, NC--(Marketwired - Sep 22, 2016) - Tergus Pharma (www.terguspharma.com) CEO, Vijendra Nalamothu, PhD, will speak at the 5th annual Innovations in Dermatological Sciences conference....
-
DURHAM, NC--(Marketwired - Jul 27, 2016) - Tergus Pharma, (www.terguspharma.com), the industry leader in topical development, formulation, analysis, testing and clinical supply manufacturing has...
-
DURHAM, NC--(Marketwired - Apr 20, 2016) - Tergus Pharma, (www.terguspharma.com), the industry leader in topical development, formulation, analysis, testing and clinical supply manufacturing...
-
SAN FRANCISCO, CA--(Marketwired - Feb 10, 2016) - In a move that will further cement Tergus Pharma's (www.terguspharma.com) position as the industry leader in topical clinical supply manufacturing,...
-
RESEARCH TRIANGLE PARK, NC--(Marketwired - Dec 10, 2015) - Tergus (www.terguspharma.com), the industry leader in topical pharmaceutical development, skin biology & IVRT testing and Phase I...
-
RESEARCH TRIANGLE PARK, NC--(Marketwired - May 19, 2015) - Tergus (www.terguspharma.com), the industry leader in topical pharmaceutical development, skin biology & IVRT testing and Phase I -...
-
RESEARCH TRIANGLE PARK, NC--(Marketwired - Apr 30, 2015) - Tergus (www.terguspharma.com), the industry leader in topical pharmaceutical development, skin biology & IVRT testing and Phase I -...